Stoke Therapeutics Inc
STOK
Market Cap$731.24M
Close$
$4.37
68.6% downside
Current Fair Value
68.6% downsideOvervalued by 68.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $731.24 Million |
|---|---|
| Enterprise Value | $552.66 Million |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $-2.42 |
| Beta | 1.86 |
| Outstanding Shares | 52,119,860 |
| Avg 30 Day Volume | 846,917 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -6.74 |
|---|---|
| PEG | -39.67 |
| Price to Sales | - |
| Price to Book Ratio | 6.95 |
| Enterprise Value to Revenue | 70.46 |
| Enterprise Value to EBIT | -4.67 |
| Enterprise Value to Net Income | -6 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
ESG Score
No data
About Stoke Therapeutics Inc
CEO: Edward Kaye